Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-09

Clinical Trial Update: Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating fibrin sealant to reduce lymphedema after lymph node–removal surgery in vulvar cancer patients; the study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrin sealant (fibrin sealant)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Lymphedema, Perioperative/Postoperative Complications | Phase 3 | Status: COMPLETED